Braun Oliver, Knipp Markus, Chesnov Serge, Vasák Milan
Department of Biochemistry, University of Zürich, CH-8057 Zürich, Switzerland.
Protein Sci. 2007 Aug;16(8):1522-34. doi: 10.1110/ps.062718507. Epub 2007 Jun 28.
S-Transnitrosation is an important bioregulatory process whereby NO(+) equivalents are transferred between S-nitrosothiols and Cys of target proteins. This reaction proceeds through a common intermediate R-S-N(O(-))-S-R' and it has been proposed that products different from S-nitrosothiols may be formed in protein cavities. Recently, we have reported on the formation of such a product, an N-thiosulfoximide, at the active site of the Cys hydrolase dimethylargininase-1 (DDAH-1) upon reaction with S-nitroso-l-homocysteine (HcyNO). Here we have addressed the question of whether this novel product can also be formed with the endogenously occurring S-nitrosothiols S-nitroso-l-cysteine (CysNO) and S-nitrosoglutathione (GSNO). Further, to explore the reason responsible for the unique formation of an N-thiosulfoximide in DDAH-1 we have expanded these studies to cytidine triphosphate synthetase (CTPS), which shows a similar active site architecture. ESI-MS and activity measurements showed that the bulky GSNO does not react with both enzymes. In contrast, S-nitrosylation of the active site Cys occurred in DDAH-1 with CysNO and in CTPS with CysNO and HcyNO. Although kinetic analysis indicated that these compounds act as specific irreversible inhibitors, no N-thiosulfoximide was formed. The reasons likely responsible for the absence of the N-thiosulfoximide formation are discussed using molecular models of DDAH-1 and CTPS. In tissue extracts DDAH was inhibited only by HcyNO, with an IC(50) value similar to that of the isolated protein. Biological implications of these studies for the function of both enzymes are discussed.
S-亚硝基化是一种重要的生物调节过程,通过该过程,NO(+)等价物在S-亚硝基硫醇与靶蛋白的半胱氨酸之间转移。该反应通过共同中间体R-S-N(O(-))-S-R'进行,有人提出在蛋白质腔中可能形成不同于S-亚硝基硫醇的产物。最近,我们报道了在半胱氨酸水解酶二甲基精氨酸酶-1(DDAH-1)的活性位点与S-亚硝基-L-高半胱氨酸(HcyNO)反应时形成了这样一种产物,即N-硫代亚磺酰亚胺。在此,我们探讨了这种新型产物是否也能由内源性存在的S-亚硝基硫醇S-亚硝基-L-半胱氨酸(CysNO)和S-亚硝基谷胱甘肽(GSNO)形成。此外,为了探究DDAH-1中N-硫代亚磺酰亚胺独特形成的原因,我们将这些研究扩展到了胞苷三磷酸合成酶(CTPS),其显示出相似的活性位点结构。电喷雾电离质谱(ESI-MS)和活性测量表明,体积较大的GSNO不与这两种酶发生反应。相比之下,活性位点半胱氨酸的亚硝基化在DDAH-1中与CysNO发生,在CTPS中与CysNO和HcyNO发生。尽管动力学分析表明这些化合物作为特异性不可逆抑制剂起作用,但未形成N-硫代亚磺酰亚胺。使用DDAH-1和CTPS的分子模型讨论了可能导致未形成N-硫代亚磺酰亚胺的原因。在组织提取物中,DDAH仅被HcyNO抑制,其IC(50)值与分离的蛋白质相似。讨论了这些研究对两种酶功能的生物学意义。